Form 4: Akamai CTO Sells Shares Under Pre-Arranged 10b5-1 Plan

Akamai Technologies' Chief Technology Officer, Robert Blumofe, sold 3,500 shares of common stock for $97 per share on January 22, 2026, under a pre-arranged 10b5-1 plan.

Summary

• Robert Blumofe, Chief Technology Officer of Akamai Technologies Inc. (AKAM), reported a sale of common stock.
• The transaction involved the disposition of 3,500 shares of common stock at a price of $97 per share.
• The sale occurred on January 22, 2026.
• This transaction was executed pursuant to a Rule 10b5-1 Plan adopted by Dr. Blumofe on March 12, 2025.
• Following the transaction, Robert Blumofe directly beneficially owns 18,074 shares of common stock.
• An additional 90.985 shares are indirectly beneficially owned through a 401(k) Plan as of January 22, 2026.

Sentiment

Score: 4

Explanation: The sale of shares by a Chief Technology Officer, even under a pre-arranged 10b5-1 plan, is generally viewed as a neutral to slightly negative signal as it reduces insider ownership, though the pre-planned nature mitigates immediate concerns about new negative information.

Positives

• The sale was conducted under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on new, non-public information.

Negatives

• An insider sale reduces the direct ownership stake of a key executive in the company.

Risks

• Potential for negative market perception regarding insider selling, even if pre-planned.

Future Outlook

N/A. This filing reports a past insider transaction and does not contain forward-looking statements or guidance.

Industry Context

N/A. This Form 4 filing details an individual insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Related Party Transactions

• The transaction involves the sale of common stock by Robert Blumofe, Chief Technology Officer, which is considered an insider transaction.

Stakeholder Impact

• Shareholders may interpret the insider sale as a signal, potentially leading to questions about management's long-term confidence, although the 10b5-1 plan mitigates this concern.

Key Dates

Recommendation

The sale of shares by Akamai's CTO, Robert Blumofe, was executed under a pre-arranged Rule 10b5-1 plan, which suggests the transaction was scheduled in advance and not based on recent material non-public information. While insider selling can sometimes be a negative signal, the pre-planned nature reduces its immediate bearish implications. This single transaction, representing a portion of his holdings, does not fundamentally alter the investment thesis for Akamai, warranting a 'hold' recommendation rather than a 'sell' or 'strong sell'.

Keywords

Akamai Technologies, AKAM, Insider Trading, Form 4, Stock Sale, Robert Blumofe, Chief Technology Officer, 10b5-1 Plan, Equity Transaction